Physician

Gregory John Fulchiero, M.D., M.S.

According to 2025 Medicare claims, Gregory Fulchiero, M.D., M.S. (NPI: 1942414115) practices dermatology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is KEYSTONE DERMATOLOGY & CENTER FOR SKIN SURGERY, LLC (NPI: 1558549733; TIN: 383775759) and primary practice location at 16602-2014.

Fulchiero's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,648 traditional Medicare patients, billed 35,664 HCPCS/CPT codes, and received $1,004,638 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 4,556 prescription claims across 1,659 beneficiaries totaling $3,288,094 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2018 DME data shows 12 claims. Open Payments data shows 162 records totaling $3,032. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $544,595 to $1,004,638. Similarly, Part D prescription costs have moved sharply higher in recent years, from $413,733 to $3,288,094. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,336	6,953	$544,595
2016	1,486	8,212	$595,783
2017	1,653	8,451	$701,407
2018	1,763	12,794	$670,448
2019	1,941	21,088	$749,863
2020	1,855	22,954	$733,442
2021	1,977	26,316	$846,297
2022	2,202	26,473	$912,992
2023	2,565	28,496	$982,088
2024	2,648	35,664	$1,004,638

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	642	1,618	$413,733
2016	659	1,756	$460,963
2017	737	2,007	$820,286
2018	833	2,351	$1,213,250
2019	938	2,749	$1,600,720
2020	1,030	3,122	$1,502,093
2021	1,013	2,962	$1,351,867
2022	1,183	3,353	$1,734,264
2023	1,474	4,082	$2,552,203
2024	1,659	4,556	$3,288,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$1,322
2018	N/R	12	$1,151
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	463	545	$77
11102	Biopsy of related skin growth, first growth	805	967	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,727	2,235	$61
17000	Destruction of precancer skin growth, 1 growth	976	1,248	$37
17003	Destruction of precancer skin growth, 2-14 growths	742	4,551	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	52	1,456	$766,813
Erivedge	Vismodegib	43	1,278	$626,343
Otezla	Apremilast	95	2,850	$443,038
Dupixent Syringe	Dupilumab	72	2,240	$296,204
Xolair	Omalizumab	51	1,582	$137,194

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	162	$3,032	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory John Fulchiero, M.D., M.S.?

Tedicare shows public-source Medicare data for Gregory John Fulchiero, M.D., M.S. (NPI 1942414115), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory John Fulchiero, M.D., M.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory John Fulchiero, M.D., M.S.?

Gregory John Fulchiero, M.D., M.S. is linked to KEYSTONE DERMATOLOGY & CENTER FOR SKIN SURGERY, LLC (billing NPI 1558549733) in the available physician profile data.

Does Gregory John Fulchiero, M.D., M.S. have Open Payments data?

Gregory John Fulchiero, M.D., M.S. has 162 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.